Related Articles
PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer
Rotundic acid induces Cas3‑MCF‑7 cell apoptosis through the p53 pathway
Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation
MUC1 and maltose‑binding protein recombinant fusion protein combined with Bacillus Calmette‑Guerin induces MUC1‑specific and nonspecific anti‑tumor immunity in mice
Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer